Archive · 23 Jan 2026
Abbott Halts Codeine-Based Phensedyl Amid Misuse Concerns
Abbott, a healthcare company, stopped making and selling a cough syrup called Phensedyl that has codeine in it.
They did this because there were problems with people misusing the medicine.
Abbott had been taking steps to prevent this, like setting limits on how much they made and sold, and only selling to approved distributors.
Even with these steps, the misuse continued, so they decided to stop making the codeine version.
They also mentioned that regulators checked their factory and were satisfied.
Phensedyl has been around since the 1950s and is used to treat coughs from colds, flu, and serious illnesses like cancer and tuberculosis.
Abbott ceased manufacturing and selling codeine-based Phensedyl in December 2024 due to misuse concerns.
The company had implemented measures like setting supply limits and conducting distributor education programs.
Despite these efforts, misuse and diversion of the product persisted.
Regulators inspected Abbott's Baddi manufacturing site on January 14, 2026, and found the inspection satisfactory.
Phensedyl, launched in the 1950s, is a prescription cough syrup used to treat various conditions.
- Who
- Abbott
- What
- Ceased manufacturing and selling codeine-based Phensedyl
- When
- December 2024
- Where
- India
- Why
- To prevent misuse and diversion of the product
- Company
- Abbott
- Product
- Phensedyl (codeine-based)
- Action Taken
- Ceased manufacturing and selling codeine-based Phensedyl
- Date of Cessation
- December 2024
- Regulatory Inspection
- January 14, 2026
- Product Launch
- 1950s
- Codeine Content
- 0.2% Codeine Phosphate
- Production Decline
- 50% between 2012-2024